Page last updated: 2024-12-07

1,2,3,4-tetrahydro-1-phenylisoquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,3,4-tetrahydro-1-phenylisoquinoline, also known as **1-phenyl-1,2,3,4-tetrahydroisoquinoline (1-PTI)**, is a chemical compound with the formula C16H17N. It's a heterocyclic aromatic amine that holds significant importance in research due to its potential for various applications, including:

**1. Pharmaceutical Research:**

* **Neurotransmitter Release Modulation:** 1-PTI acts as a **potent inhibitor of dopamine release** in the brain. This property makes it a valuable tool for studying the role of dopamine in various neurological disorders like Parkinson's disease, addiction, and schizophrenia.
* **Anxiolytic and Antidepressant Effects:** Studies suggest that 1-PTI may exhibit anxiolytic and antidepressant properties. Its ability to modulate dopamine and serotonin neurotransmission contributes to its potential therapeutic benefits.
* **Anti-Inflammatory Activity:** Research indicates that 1-PTI possesses anti-inflammatory properties, making it a potential lead compound for developing new anti-inflammatory medications.

**2. Chemical Research:**

* **Synthesis and Chemical Modifications:** 1-PTI serves as a **starting material for the synthesis of various novel compounds** with potential biological activities. Chemists can modify its structure to create new drugs or explore its potential as a building block for organic materials.
* **Drug Development:** 1-PTI's structure can be modified to develop new pharmaceutical agents. The understanding of its pharmacological activity can help in designing new drugs targeting specific receptors or enzymes in the body.
* **Analytical Chemistry:** 1-PTI can be used as a **reference standard** in analytical chemistry to identify and quantify other compounds through techniques like chromatography and mass spectrometry.

**3. Material Science:**

* **Organic Electronics:** 1-PTI's electronic properties make it a candidate for use in organic electronic devices like organic light-emitting diodes (OLEDs) and organic field-effect transistors (OFETs).

**Overall, the importance of 1,2,3,4-tetrahydro-1-phenylisoquinoline lies in its diverse applications, including its potential therapeutic use, its role as a building block in chemical synthesis, and its applicability in developing novel materials.**

However, it's important to note that 1-PTI is still under investigation, and further research is needed to fully understand its properties and potential risks before it can be used clinically.

1,2,3,4-tetrahydro-1-phenylisoquinoline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID100137
CHEMBL ID21465
SCHEMBL ID327233
SCHEMBL ID12046710
MeSH IDM0254498

Synonyms (46)

Synonym
AC-685
1-phenyl-1,2,3,4-tetrahydro-isoquinoline
BAS 01118689 ,
nsc338399
22990-19-8
nsc-338399
CHEMBL21465 ,
AKOS000272849
1-phenyl-1,2,3,4-tetrahydroisoquinoline ,
bdbm50017035
A4871
A18116
NCGC00245237-01
EN300-72483
racemic 1-phenyl-1,2,3,4-tetrahydro-isoquinoline
A816462
1-phenyl-1,2,3,4-tetrahydroisoquinoline;1-phenyl-1,2,3,4-tetrahydro-isoquinoline
STL253537
nsc 338399
isoquinoline, 1,2,3,4-tetrahydro-1-phenyl-
phenyl-tiq
1,2,3,4-tetrahydro-1-phenylisoquinoline
FT-0638277
FT-0603857
CS-B0307
SCHEMBL327233
P2056
AKOS016040456
mfcd02179241
SY030993
(s)-1,2,3,4-tetrahydro-1-phenylisoquinoline
SCHEMBL12046710
Q-101004
1-phenyl-1,2,3,4-tetrahydro-isoquinoline, aldrichcpr
SY025337
Z1741966190
FT-0689458
AS-15682
BCP12873
BCP14564
AMY40172
SB31601
SB34419
SB35629
rac 1-phenyl-1,2,3,4-tetrahydroisoquinoline
PD119414
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Lysosomal Pro-X carboxypeptidaseHomo sapiens (human)IC50 (µMol)1.90000.00530.60331.9000AID157589
Sigma non-opioid intracellular receptor 1Rattus norvegicus (Norway rat)IC50 (µMol)2.00000.00030.55704.2000AID204608
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
regulation of thyroid hormone mediated signaling pathwayLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
plasma kallikrein-kinin cascadeLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
proteolysisLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
glucose homeostasisLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
energy homeostasisLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
regulation of reactive oxygen species metabolic processLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
angiogenesis involved in wound healingLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
negative regulation of systemic arterial blood pressureLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
regulation of blood vessel endothelial cell migrationLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
serine-type carboxypeptidase activityLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
protein bindingLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
dipeptidyl-peptidase activityLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
plasma membraneLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
azurophil granule membraneLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
intracellular membrane-bounded organelleLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
basal part of cellLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
extracellular exosomeLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
ficolin-1-rich granule membraneLysosomal Pro-X carboxypeptidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID710417Neuroprotective activity in mouse hippocampal neurons assessed as Abeta-induced neuronal apoptosis at 30 uM pre-incubated for 4 hrs before Abeta challenge for 72 hrs by TUNEL assay (Rvb = 100%)2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor.
AID157589Inhibition of [3H]1-[1-(2-thienyl) piperidine ([3H]TCP) binding to phencyclidine receptor1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.
AID710418Inhibition of imidazole receptor 2 in mouse hippocampal neurons assessed as reduction in tPA-induced Erk1/2 activation at 30 uM pre-incubated for 4 hrs before tPA stimulation by ELISA2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor.
AID710414Inhibition of radioligand binding to N-methyl D-aspartate receptor phencyclidine binding site at 10 uM2012Journal of medicinal chemistry, Nov-26, Volume: 55, Issue:22
Identification of small molecule inhibitors of amyloid β-induced neuronal apoptosis acting through the imidazoline I(2) receptor.
AID157586Compound was tested for induction of phencyclidine (PCP) like ataxia behavior1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.
AID157587Compound was tested for induction of phencyclidine (PCP) like stereotyped behavior1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.
AID204608Inhibition of [3H]- N-allylnormetazocine ([3H]NANM) binding to sigma receptor1989Journal of medicinal chemistry, Jun, Volume: 32, Issue:6
Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.69 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]